Profile picture

Assistant Professor Evangelos Giannitsis

University Hospital Heidelberg, Heidelberg (Germany)
Membership: FESC Member ACVC Member
Follow
Biography
Assistant Professor of Medicine in Heidelberg. After gaining his medical degree from the University of Homburg, Prof. Giannitsis completed postgraduate training in internal medicine and cardiology at Lübeck University Hospital, Germany. Subsequently, he undertook a PhD in internal medicine before his current position in 2002. Prof. Giannitsis’s research interests focus on cardiac biomarkers, i.e. troponins, and their validation in the diagnosis of coronary syndromes, as well as cardiac MR imaging. He has been the Principal National Coordinator in many clinical trials in these fields including the PLATO trial, the ATLAS-TIMI 46 and ATLAS-TIMI 51 trials. He is a member of numerous professional societies including the European Society of Cardiology: He served as a member of the program committee for the ESC from 2010-2012, and he is a founder of the Chest Pain Unit initiative of the German Society of Cardiology and currently the Chair of the certification committee for Chest Pain Units.
Logo ESC

Contributor content

Risk factors, prevention, and pharmacotherapy
Session
Risk factors, prevention, and pharmacotherapy
9 March 2024
Digital tools for empowered decision making in the ED
Session
Digital tools for empowered decision making in the ED
9 March 2024
Artificial intelligence in acute cardiology
Session
Artificial intelligence in acute cardiology
25 March 2023
Chest discomfort and dyspnea in acute cardiac care: state of the art biomarkers in ACS and its differential diagnoses.
Session
Chest discomfort and dyspnea in acute cardiac care: state of the art biomarkers in ACS and its differential diagnoses.
24 March 2023
Innovative digital solutions for optimal management of cardiovascular diseases
Session
Innovative digital solutions for optimal management of cardiovascular diseases
26 August 2022
Troponin and other biomarkers in acute coronary syndromes
Session
Troponin and other biomarkers in acute coronary syndromes
26 August 2022
Cardiac troponins and other biomarkers in acute coronary syndromes
Session
Cardiac troponins and other biomarkers in acute coronary syndromes
2 September 2019
From trial to treatment in vascular protection: which high risk patients benefit the most?
Session
From trial to treatment in vascular protection: which high risk patients benefit the most?
31 August 2019
Controversies in diagnostic strategies for chest pain patients
Session
Controversies in diagnostic strategies for chest pain patients
3 March 2019

ESC 365 is supported by